A federal court in Missouri has dismissed a legal challenge by drugmaker AbbVie to the state’s new 340B contract pharmacy law, which aims to regulate how pharmaceutical companies interact with contract pharmacies.
The order, filed July 11 in the U.S. District Court for the Eastern District of Missouri, sided with Missouri Attorney General Andrew Bailey who had moved to dismiss the case, according to court documents reviewed by Becker’s.
AbbVie filed the lawsuit earlier this year, alleging that Missouri’s 340B law conflicted with federal 340B program regulations and was unconstitutional. However, the court ruled that AbbVie lacked standing, finding insufficient justification for moving the case forward.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
